¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ½ÃÀå
The Global Influenza Market
»óǰÄÚµå : 1724763
¸®¼­Ä¡»ç : BCC Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 188 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,650 £Ü 6,495,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,580 £Ü 7,794,000
PDF & Excel (2-5 Users) help
PDF ¹× Excel º¸°í¼­¸¦ 2-5¸íÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,696 £Ü 9,353,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,035 £Ü 11,224,000
PDF & Excel (Enterprise License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ½ÃÀå ±Ô¸ð´Â 2024³â 90¾ï ´Þ·¯¿¡¼­ 2029³â ¸» 128¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2029³â ¿¹Ãø ±â°£ µ¿¾È CAGR 7.2%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

ºÏ¹Ì ½ÃÀåÀº 2024³â 45¾ï ´Þ·¯¿¡¼­ 2029³â¿¡´Â 63¾ï ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖÀ¸¸ç, ÀÌ ±â°£ CAGR 7.3%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. À¯·´ ½ÃÀåÀº 2024³â 24¾ï ´Þ·¯¿¡¼­ 2029³â 33¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î Àü¸ÁµÇ¸ç, CAGR 6.8%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ÀÎÇ÷翣ÀÚ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâÀÎÀÚ ¹× ½ÃÀå ±âȸ ºÐ¼®, ¹ý±ÔÁ¦ ȯ°æ, ½ÅÈï±â¼ú ¹× ±â¼ú °³¹ß µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢Á¾ ±¸ºÐ, Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ

Á¦4Àå ±ÔÁ¦ »óȲ

Á¦5Àå »õ·Î¿î µ¿Çâ ¹× ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®

Á¦7Àå °æÀï Á¤º¸

Á¦8Àå ÀÎÇ÷翣ÀÚ ½ÃÀå¿¡¼­ÀÇ Áö¼Ó°¡´É¼º : ESGÀÇ °üÁ¡

Á¦9Àå ºÎ·Ï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029.

The North American influenza market is expected to grow from $4.5 billion in 2024 and is projected to reach $6.3 billion by the end of 2029, at a CAGR of 7.3% during the forecast period of 2024 to 2029.

The European influenza market is expected to grow from $2.4 billion in 2024 and is projected to reach $3.3 billion by the end of 2029, at a CAGR of 6.8% during the forecast period of 2024 to 2029.

Report Scope

This report presents qualitative and quantitative data on the current dynamics impacting the global influenza market. It examines the history of various flu pandemics, disease burden and vaccine coverage in several countries. The report thoroughly evaluates the market for influenza vaccines, therapeutics and diagnostics.

Analyses of the most popular products, clinical trials, new product approvals and emerging technologies are also included in the report. The demographics of the major regions-North America, Europe and Asia-Pacific-and their growth prospects are summarized. The profiles of leading companies and the strategies of international businesses involved in the influenza sector are also discussed.

The market size for influenza is categorized into three product segments: vaccines, therapeutics and diagnostics. Vaccines are further segmented into inactivated vaccines and live-attenuated vaccines. Diagnostics are divided into rapid and conventional lab tests. Additional growth potential and forecast data are addressed for the influenza market in each product segment for every region.

For market estimates, data are provided for 2023 as the base year, 2024 as the estimated year and forecast from 2025 through 2029.

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Trends and Pipeline Analysis

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in Influenza Market: ESG Perspective

Chapter 9 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â